OR WAIT null SECS
February 18, 2014
DIR Technologies will work with Pfizer to perform a three-month trial of the company's packaging integrity testing systems.
January 31, 2014
Teva reports FDA approval for three-times-a-week Copaxone 40 mg/mL.
January 22, 2014
Teva announced an agreement to acquire NuPathe and its migraine treatment patch.
NovePen Echo is the first insulin injection device combining half-unit dosing and memory function
J&J's diagnostics business goes to global asset manager, The Carlyle Group.
The Natural Product Center of Excellence seeks to identify novel active compounds for new antibiotics.
January 09, 2014
Research was published describing a natural interferon-alpha for infection control and treatment of drug-resistant H7N9 influenza.
Forest's planned acquisition of Aptalis will enhance its business in gastrointestinal and cystic fibrosis therapies.
Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.
January 06, 2014
GE acquires Thermo Fisher's HyClone cell culture media and sera products, gene modulation technologies, and magnetic beads businesses.